Gene · 5978
Papers4,251
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,251
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma. | Leukemia | 2023 | 37648814 | PubTator, text mining | PubMed |
| Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential. | Signal Transduct Target Ther | 2023 | 37644009 | PubTator, text mining | PubMed |
| The Impact of Hormesis, Neuronal Stress Response, and Reproduction, upon Clinical Aging: A Narrative Review. | J Clin Med | 2023 | 37629475 | PubTator, text mining | PubMed |
| From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington's Disease Research. | Int J Mol Sci | 2023 | 37629202 | PubTator, text mining | PubMed |
| Tumor Suppressor Properties of Small C-Terminal Domain Phosphatases in Clear Cell Renal Cell Carcinoma. | Int J Mol Sci | 2023 | 37629167 | PubTator, text mining | PubMed |
| Targeted Therapy for EWS-FLI1 in Ewing Sarcoma. | Cancers (Basel) | 2023 | 37627063 | PubTator, text mining | PubMed |
| Brain-Derived Neurotrophic Factor Dysregulation as an Essential Pathological Feature in Huntington's Disease: Mechanisms and Potential Therapeutics. | Biomedicines | 2023 | 37626771 | PubTator, text mining | PubMed |
| A new diagnostic tool for brain disorders: extracellular vesicles derived from neuron, astrocyte, and oligodendrocyte. | Front Mol Neurosci | 2023 | 37621405 | PubTator, text mining | PubMed |
| Implementation and prospective real-time evaluation of a generalized system for in-clinic deployment and validation of machine learning models in radiology. | PLOS Digit Health | 2023 | 37603542 | PubTator, text mining | PubMed |
| Protein Expression of NEK2, JMJD4, and REST in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical, Pathological, and Prognostic Findings. | Iran J Pathol | 2023 | 37600577 | PubTator, text mining | PubMed |
| Epigenetic signature of human immune aging in the GESTALT study. | Elife | 2023 | 37589453 | PubTator, text mining | PubMed |
| Integrative Genomic Analyses Identify LncRNA Regulatory Networks across Pediatric Leukemias and Solid Tumors. | Cancer Res | 2023 | 37584517 | PubTator, text mining | PubMed |
| The mechanisms crosstalk and therapeutic opportunities between ferroptosis and ovary diseases. | Front Endocrinol (Lausanne) | 2023 | 37564979 | PubTator, text mining | PubMed |
| Protein regulator of cytokinesis 1: a potential oncogenic driver. | Mol Cancer | 2023 | 37563591 | PubTator, text mining | PubMed |
| Universal DNA methylation age across mammalian tissues. | Nat Aging | 2023 | 37563227 | PubTator, text mining | PubMed |
| Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study. | Cancer Epidemiol Biomarkers Prev | 2023 | 37555839 | PubTator, text mining | PubMed |
| Multi-omics profiling of CSF from spinal muscular atrophy type 3 patients after nusinersen treatment: a 2-year follow-up multicenter retrospective study. | Cell Mol Life Sci | 2023 | 37543540 | PubTator, text mining | PubMed |
| A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression. | Cancer Lett | 2023 | 37543278 | PubTator, text mining | PubMed |
| Integrated multiomics analysis of chromosome 19 miRNA cluster in bladder cancer. | Funct Integr Genomics | 2023 | 37542643 | PubTator, text mining | PubMed |
| Two opposing gene expression patterns within ATRX aberrant neuroblastoma. | PLoS One | 2023 | 37540673 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5978/papers?page=17